• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Extensile Anterior and Posterior Knee Exposure for Complete Synovectomy of Diffuse Tenosynovial Giant Cell Tumor (Pigmented Villonodular Synovitis).用于弥漫性腱鞘巨细胞瘤(色素沉着绒毛结节性滑膜炎)全滑膜切除术的膝关节前后广泛显露
JBJS Essent Surg Tech. 2022 May 25;12(2). doi: 10.2106/JBJS.ST.21.00035. eCollection 2022 Apr-Jun.
2
Cementless, Cruciate-Retaining Primary Total Knee Arthroplasty Using Conventional Instrumentation: Technical Pearls and Intraoperative Considerations.使用传统器械的非骨水泥型、保留交叉韧带初次全膝关节置换术:技术要点与术中注意事项
JBJS Essent Surg Tech. 2024 Sep 13;14(3). doi: 10.2106/JBJS.ST.23.00036. eCollection 2024 Jul-Sep.
3
Arthroscopic Synovectomy for Tenosynovial Giant Cell Tumor/Pigmented Villonodular Synovitis in the Posterior Knee Using the Posterior Trans-Septal Portal Technique.采用后间隔入路技术行关节镜下滑膜切除术治疗膝关节后方的腱鞘巨细胞瘤/色素沉着绒毛结节性滑膜炎
JBJS Essent Surg Tech. 2022 Mar 21;12(1). doi: 10.2106/JBJS.ST.21.00051. eCollection 2022 Jan-Mar.
4
What Are the Recurrence Rates, Complications, and Functional Outcomes After Multiportal Arthroscopic Synovectomy for Patients With Knee Diffuse-type Tenosynovial Giant-cell Tumors?膝关节弥漫型腱鞘巨细胞瘤患者行多入路关节镜下滑膜切除术的复发率、并发症及功能结局如何?
Clin Orthop Relat Res. 2024 Jul 1;482(7):1218-1229. doi: 10.1097/CORR.0000000000002934. Epub 2023 Dec 28.
5
Distinct extra-articular invasion patterns of diffuse pigmented villonodular synovitis/tenosynovial giant cell tumor in the knee joints.膝关节弥漫性色素绒毛结节性滑膜炎/腱鞘巨细胞瘤的关节外侵袭模式明显不同。
Knee Surg Sports Traumatol Arthrosc. 2018 Nov;26(11):3508-3514. doi: 10.1007/s00167-018-4942-2. Epub 2018 Apr 10.
6
Talar Arthroscopic Reduction and Internal Fixation (TARIF): A Novel All-Inside Soft-Tissue-Preserving Technique.距骨关节镜下复位与内固定(TARIF):一种新型的全关节内软组织保留技术。
JBJS Essent Surg Tech. 2023 Feb 28;13(1). doi: 10.2106/JBJS.ST.22.00007. eCollection 2023 Jan-Mar.
7
Inside-Out Repair of Medial Meniscal Ramp Lesions in Patients Undergoing Anterior Cruciate Ligament Reconstruction.前交叉韧带重建患者内侧半月板斜坡损伤的由内向外修复
JBJS Essent Surg Tech. 2024 Oct 3;14(4). doi: 10.2106/JBJS.ST.22.00037. eCollection 2024 Oct-Dec.
8
Midterm outcomes of 18 patients with primary intra-articular diffuse tenosynovial giant cell tumor (TGCT) of the knee treated with complete arthroscopic synovectomy and postoperative low-dose radiotherapy at a mean follow-up of 68 months.18例原发性膝关节关节内弥漫性腱鞘巨细胞瘤(TGCT)患者接受了完全关节镜下滑膜切除术及术后低剂量放疗,平均随访68个月的中期结果。
Arch Orthop Trauma Surg. 2023 Apr;143(4):2121-2127. doi: 10.1007/s00402-022-04465-7. Epub 2022 May 14.
9
Does combined open and arthroscopic synovectomy for diffuse PVNS of the knee improve recurrence rates?膝关节弥漫性色素沉着绒毛结节性滑膜炎行关节镜下与切开滑膜切除术联合治疗是否能降低复发率?
Clin Orthop Relat Res. 2013 Mar;471(3):883-90. doi: 10.1007/s11999-012-2589-8.
10
[Traumatic knee dislocation with popliteal vascular disruption: retrospective study of 14 cases].[伴有腘血管损伤的创伤性膝关节脱位:14例回顾性研究]
Rev Chir Orthop Reparatrice Appar Mot. 2006 Dec;92(8):768-77. doi: 10.1016/s0035-1040(06)75945-1.

引用本文的文献

1
Diffuse-Type Tenosynovial Giant Cell Tumor of the Knee: Clinical Course After Anterior Open Synovectomy.膝关节弥漫型腱鞘巨细胞瘤:前路开放性滑膜切除术后的临床病程
Curr Oncol. 2025 Jun 11;32(6):342. doi: 10.3390/curroncol32060342.
2
Combination of manual lymphatic drainage and Kinesio taping for treating pigmented villonodular synovitis: A case report.手法淋巴引流与肌内效贴布联合治疗色素沉着绒毛结节性滑膜炎:一例报告。
World J Clin Cases. 2024 Jul 6;12(19):3971-3977. doi: 10.12998/wjcc.v12.i19.3971.
3
Recurrence-Free Survival after Synovectomy and Subsequent Radiosynoviorthesis in Patients with Synovitis of the Knee-A Retrospective Data Analysis.膝关节滑膜炎患者滑膜切除术后及后续放射性滑膜切除术后的无复发生存率——一项回顾性数据分析
J Clin Med. 2024 Jan 21;13(2):601. doi: 10.3390/jcm13020601.

本文引用的文献

1
Management of Pigmented Villonodular Synovitis (PVNS): an Orthopedic Surgeon's Perspective.色素沉着绒毛结节性滑膜炎(PVNS)的治疗:矫形外科医生的视角。
Curr Oncol Rep. 2020 Jun 4;22(6):63. doi: 10.1007/s11912-020-00926-7.
2
Surgical outcomes of patients with diffuse-type tenosynovial giant-cell tumours: an international, retrospective, cohort study.弥漫型腱鞘巨细胞瘤患者的手术治疗效果:一项国际性回顾性队列研究。
Lancet Oncol. 2019 Jun;20(6):877-886. doi: 10.1016/S1470-2045(19)30100-7. Epub 2019 Apr 24.
3
Pigmented Villonodular Synovitis: A Comprehensive Review and Proposed Treatment Algorithm.色素沉着绒毛结节性滑膜炎:全面综述及建议的治疗方案
JBJS Rev. 2016 Jul 19;4(7). doi: 10.2106/JBJS.RVW.15.00086.
4
Tenosynovial giant cell tumour/pigmented villonodular synovitis: outcome of 294 patients before the era of kinase inhibitors.腱鞘巨细胞瘤/色素绒毛结节性滑膜炎:激酶抑制剂时代前 294 例患者的预后。
Eur J Cancer. 2015 Jan;51(2):210-7. doi: 10.1016/j.ejca.2014.11.001. Epub 2014 Nov 24.
5
Does combined open and arthroscopic synovectomy for diffuse PVNS of the knee improve recurrence rates?膝关节弥漫性色素沉着绒毛结节性滑膜炎行关节镜下与切开滑膜切除术联合治疗是否能降低复发率?
Clin Orthop Relat Res. 2013 Mar;471(3):883-90. doi: 10.1007/s11999-012-2589-8.
6
Outcomes after excision of pigmented villonodular synovitis of the knee.膝关节色素沉着绒毛结节性滑膜炎切除术后的结果
Clin Orthop Relat Res. 2009 Nov;467(11):2852-8. doi: 10.1007/s11999-009-0922-7. Epub 2009 Jun 20.
7
Treatment of advanced primary and recurrent diffuse pigmented villonodular synovitis of the knee.晚期原发性及复发性膝关节弥漫性色素沉着绒毛结节性滑膜炎的治疗
J Bone Joint Surg Am. 2002 Dec;84(12):2192-202. doi: 10.2106/00004623-200212000-00011.

用于弥漫性腱鞘巨细胞瘤(色素沉着绒毛结节性滑膜炎)全滑膜切除术的膝关节前后广泛显露

Extensile Anterior and Posterior Knee Exposure for Complete Synovectomy of Diffuse Tenosynovial Giant Cell Tumor (Pigmented Villonodular Synovitis).

作者信息

Lingamfelter Max, Novaczyk Zachary B, Cheng Edward Y

机构信息

Department of Orthopaedic Surgery, University of Minnesota, Minneapolis, Minnesota.

出版信息

JBJS Essent Surg Tech. 2022 May 25;12(2). doi: 10.2106/JBJS.ST.21.00035. eCollection 2022 Apr-Jun.

DOI:10.2106/JBJS.ST.21.00035
PMID:36741035
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9889289/
Abstract

UNLABELLED

Diffuse tenosynovial giant cell tumor (TGCT), also known as pigmented villonodular synovitis, is a benign, neoplastic disease of the synovium that can lead to joint destruction, osteoarthritis, and long-term morbidity. Often, there is extra-articular involvement in the intercondylar notch and posterior soft tissues. A complete anterior and posterior synovectomy of the knee is indicated for treating diffuse TGCT when the anterior and posterior compartments of the knee joint are involved. Additionally, either an anterior or posterior synovectomy may be performed when the TGCT is limited to 1 compartment of the knee. Although an anterior synovectomy is relatively straightforward technically, a posterior synovectomy is challenging because of the presence of the neurovascular and muscular structures, which limit access, and because of the infrequency of the procedure.

DESCRIPTION

The surgical technique for open anterior and posterior knee synovectomy is performed under 1 anesthetic via separate exposures with the patient initially supine and then prone. In cases of focal TGCT, in which both the anterior and posterior compartments are involved, either an anterior or posterior approach can be utilized in isolation to target the affected compartment. The anterior approach is performed via anteromedial parapatellar arthrotomy, with care to preserve the meniscal attachments and ligaments. Once the suprapatellar pouch is visualized, all tissue deep to the quadriceps muscle and tendon, extending around to the femoral periosteum, is excised en bloc. Attention is then turned to the undersurface of the patella, fat pad, distal aspect of the femur, and proximal aspect of the tibia. The tumor may be embedded within the fat pad and must be removed. Any tumor remnants within the medial or lateral gutter or beneath the menisci are excised with use of a standard or pituitary rongeur or curets. The quadriceps tendon, subcutaneous tissue, and skin are closed over a deep drain, and the patient is turned prone and re-prepared for the posterior approach. The posterior synovectomy utilizes an S-shaped incision either superolateral to inferomedial or superomedial to inferolateral, depending on the location of the TGCT. The popliteal artery and vein and the tibial and common peroneal nerves are identified, mobilized, and protected during retraction. This step requires ligating the geniculate and other small branches of the popliteal artery and vein. To expose the posterior femoral condyle, the medial and/or lateral heads of the gastrocnemius must be tagged and released by dividing the myotendinous origin from the posterior aspect of the femur at the proximal extent of the condyle.

ALTERNATIVES

Although surgical resection is the primary treatment for TGCT, nonsurgical alternatives include radiation therapy (either external beam or radiosynoviorthesis) and the use of pharmacologic agents. Radiation therapy is associated with complications such as irreversible skin changes, arthrofibrosis, arthritis, osteonecrosis, and radiation-induced sarcoma. Systemic agents such as tyrosine kinase inhibitors (e.g., nilotinib and imatinib) or agents targeting the CSF-1 (colony-stimulating factor-1) pathway (e.g., pexidartinib and emactuzumab) are active against TGCT. The agents are typically employed in recurrent, advanced, and unresectable situations in which surgical morbidity would outweigh the therapeutic benefit. Aside from open synovectomy, arthroscopic synovectomy-usually anterior-has been utilized by some centers.

RATIONALE

To our knowledge, there is no Level-I study indicating the superiority of 1 surgical technique over the other treatments for diffuse TGCT. Anterior arthroscopic synovectomy, in isolation, for diffuse TGCT has demonstrated recurrence rates as high as 92% to 94%. Recent studies comparing anterior and posterior open and arthroscopic synovectomy have demonstrated mixed results, are limited by being retrospective, and are subject to selection bias because of the open synovectomy being selected for more extensive disease. The mixed results may a result of variation in both tumor size and location about the knee joint. The benefit of an open anterior and posterior synovectomy is that it can provide optimal exposure for large and extra-articular tumor masses that would not be accessible using an arthroscopic approach and allows for complete, gross total excision without morsellization of the tumor. The surgeon must be familiar and facile with vascular dissection techniques, even if the soft tissues surrounding the vascular structures are preserved as much as possible, in an effort to minimize postoperative edema.

EXPECTED OUTCOMES

Open anterior and posterior synovectomy provides improved exposure for large and extra-articular tumor masses and has a 5-year recurrence-free survival of 29% to 33%. Pain associated with diffuse TGCT has been demonstrated to improve in 59% of cases, with swelling reported to improve by 72% in patients following surgical intervention. No significant difference has been reported when comparing open versus arthroscopic synovectomy in terms of arthritic progression, with 8% of patients progressing to a total knee arthroplasty at a mean follow-up of 40 months.

IMPORTANT TIPS

Careful preoperative planning is crucial: note all locations of posteriorly located tumor on magnetic resonance imaging and in relation to anatomic landmarks and neurovascular structures in order to guide dissection.It can be advantageous to have multiple blunt retractor options available when dissecting in tight spaces.Be prepared for vessel ligation with free ties, vessel clips, and additional clamps.The technical ability to dissect and mobilize the popliteal vessels is essential, but this step can be tedious.At the time of incision, preserve the integrity of the popliteal fascia to facilitate a good closure later, as this step avoids the herniation of tissues in the popliteal fossa. Because this fascial tissue is fragile, the use of a monofilament rather than braided suture in addition to the placement of far-near-near-far-type figure-of-8 sutures minimizes the risk of tearing the fascia during reapproximation.To ease retraction of the soft tissues, slightly flex the knee to relax the hamstring and other muscles and neurovascular structures. This will also reduce the risk of a postoperative nerve palsy.Although separate instruments for the anterior and posterior portions of the procedure are not necessary, separate drapes, gown, and gloves and other preoperative preparation should be readied in advance for the second portion of the procedure in order to save operative time.

ACRONYMS & ABBREVIATIONS: PVNS = pigmented villonodular synovitisROM = range of motionMRI = magnetic resonance imagingGastroc = gastrocnemiusPDS = polydioxanone sutureCAM = controlled ankle motionASA = acetylsalicylic acid (aspirin).

摘要

未标注

弥漫性腱鞘巨细胞瘤(TGCT),也称为色素沉着绒毛结节性滑膜炎,是一种滑膜的良性肿瘤性疾病,可导致关节破坏、骨关节炎和长期发病。通常,髁间切迹和后软组织会出现关节外受累。当膝关节的前后间室均受累时,建议对膝关节进行完整的前后滑膜切除术以治疗弥漫性TGCT。此外,当TGCT局限于膝关节的1个间室时,可进行前侧或后侧滑膜切除术。尽管前侧滑膜切除术在技术上相对简单,但后侧滑膜切除术具有挑战性,因为存在神经血管和肌肉结构,这限制了手术入路,且该手术不常进行。

描述

开放性膝关节前后滑膜切除术的手术技术在1次麻醉下通过单独的暴露进行,患者最初仰卧,然后俯卧。在局灶性TGCT累及前后间室的情况下,可单独采用前侧或后侧入路来处理受累间室。前侧入路通过髌旁内侧关节切开术进行,注意保留半月板附着点和韧带。一旦髌上囊可视化,切除股四头肌和肌腱深面、延伸至股骨骨膜周围的所有组织,整块切除。然后将注意力转向髌骨下表面、脂肪垫、股骨远端和胫骨近端。肿瘤可能嵌入脂肪垫内,必须切除。使用标准咬骨钳、垂体咬骨钳或刮匙切除内侧或外侧沟内或半月板下方的任何肿瘤残余物。股四头肌腱、皮下组织和皮肤在深部引流管上方缝合,患者转为俯卧位,重新准备进行后侧入路手术。后侧滑膜切除术根据TGCT的位置采用从外上到内下或从内上到外下的S形切口。在牵开过程中识别、游离并保护腘动脉、静脉以及胫神经和腓总神经。这一步需要结扎腘动脉和静脉的膝状支及其他小分支。为暴露股骨后髁,必须标记并松解腓肠肌内侧头和/或外侧头,在髁近端从股骨后侧切断肌腱起点。

替代方法

尽管手术切除是TGCT的主要治疗方法,但非手术替代方法包括放射治疗(外照射或放射性滑膜切除术)和使用药物。放射治疗会伴有诸如不可逆的皮肤改变、关节纤维化、关节炎、骨坏死和放射诱导的肉瘤等并发症。全身性药物如酪氨酸激酶抑制剂(如尼洛替尼和伊马替尼)或靶向CSF - 1(集落刺激因子 - 1)途径的药物(如培西达替尼和埃马妥珠单抗)对TGCT有效。这些药物通常用于复发、晚期和不可切除的情况,此时手术并发症会超过治疗益处。除了开放性滑膜切除术外,一些中心还采用关节镜滑膜切除术,通常是前侧关节镜滑膜切除术。

原理

据我们所知,没有I级研究表明1种手术技术在治疗弥漫性TGCT方面优于其他治疗方法。单独进行前侧关节镜滑膜切除术治疗弥漫性TGCT的复发率高达92%至94%。最近比较前侧和后侧开放性及关节镜滑膜切除术的研究结果不一,受回顾性研究的限制,且由于开放性滑膜切除术被选用于更广泛的疾病而存在选择偏倚。结果不一可能是由于膝关节周围肿瘤大小和位置的差异。开放性膝关节前后滑膜切除术的优点是它可以为使用关节镜方法无法触及的大的和关节外肿瘤块提供最佳暴露,并允许完整、大体完全切除肿瘤而不进行碎块化。外科医生必须熟悉并熟练掌握血管解剖技术,即使尽可能保留血管结构周围的软组织,以尽量减少术后水肿。

预期结果

开放性膝关节前后滑膜切除术为大的和关节外肿瘤块提供了更好的暴露,5年无复发生存率为29%至33%。已证明弥漫性TGCT相关疼痛在59%的病例中有所改善,手术干预后患者肿胀改善率报告为72%。在比较开放性与关节镜滑膜切除术在关节炎进展方面没有显著差异,平均随访40个月时,8%的患者进展为全膝关节置换术。

重要提示

仔细的术前规划至关重要:在磁共振成像上注意后位肿瘤的所有位置以及与解剖标志和神经血管结构的关系,以指导解剖。在狭小空间进行解剖时,准备多种钝性牵开器可能会有帮助。准备好游离结扎线、血管夹和额外的夹子用于血管结扎。解剖和游离腘血管的技术能力至关重要,但这一步可能很繁琐。在切开时,保留腘筋膜的完整性以便于后期良好缝合,因为这一步可避免腘窝组织疝出。由于这种筋膜组织脆弱,除了采用远近近远式8字缝合外,使用单丝而非编织缝线可将重新缝合时撕裂筋膜的风险降至最低。为便于软组织牵开,将膝关节稍微屈曲以放松腘绳肌和其他肌肉及神经血管结构。这也将降低术后神经麻痹的风险。尽管手术前后部分不需要单独的器械,但应提前准备好单独的手术单、手术衣、手套和其他术前准备,以便为手术的第二部分节省手术时间。

首字母缩略词和缩写

PVNS = 色素沉着绒毛结节性滑膜炎;ROM = 活动范围;MRI = 磁共振成像;Gastroc = 腓肠肌;PDS = 聚二氧六环酮缝线;CAM = 可控踝关节活动;ASA = 乙酰水杨酸(阿司匹林)